AR and Familial prostate cancer: Considering our finding that the vast majority of the widespread metformin-induced transcriptional changes in prostate cancer cells cannot be replicated by AICAR treatment and are thus possibly independent of AMPK, it is not surprising that metformin would also affect the AR via pathways that do not involve AMPK.